Realcan Pharmaceutical Group Co., Ltd.
Shenzhen Stock Exchange 002589.SZ
Realcan Pharmaceutical Group Co., Ltd. Free Cash Flow Yield on January 14, 2025: -5.31%
-
Realcan Pharmaceutical Group Co., Ltd. 52-week high Free Cash Flow Yield is -0.61% on December 20, 2024, which is 88.54% above the current Free Cash Flow Yield.
-
Realcan Pharmaceutical Group Co., Ltd. 52-week low Free Cash Flow Yield is -6.87% on July 25, 2024, which is -29.32% below the current Free Cash Flow Yield.
-
Realcan Pharmaceutical Group Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is -5.46%.
| Date | Free Cash Flow Yield | Market Value Added (MVA) | Price to Book Ratio (P/B) | Price to Earnings Ratio (P/E) |
|---|
| CEO | Mr. Xu Han |
| IPO Date | June 10, 2011 |
| Location | China |
| Headquarters | No. 326, Airport Road |
| Employees | 3,239 |
| Sector | Health Care |
| Industries | |
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.
Past 5 years
USD 3.86
USD 2.84
USD 0.50
USD 1.90
USD 0.61
StockViz Staff
January 16, 2025
Any question? Send us an email